#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant glioma Mitochondrial encephalomyopathy Anal squamous cell carcinoma Autoimmune hepatitis Progressive familial intrahepatic cholestasis Langerhans cell sarcoma Ependymoma Cryoglobulinaemia Chronic graft versus host disease in skin Fabry's disease Anal cancer Short stature homeobox gene mutation Epileptic encephalopathy Immunodeficiency common variable Oesophageal atresia More trials…

    Learn about Rare Diseases

    Optic glioma – Trials in Disease Congenital hypotransferrinaemia Short-bowel syndrome – Treatment Leiomyosarcoma recurrent – Diagnostics Gaucher’s disease type I – Basic Information Mantle cell lymphoma stage II Osteosarcoma – Diagnostics Piriformis syndrome – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Niemann-Pick disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GOVORESTAT F44/10 Epacadostat Deoxyribonucleic Acid Faricimab Neob TEV-53408 Nivolumab Tanimilast Guselkumab Eight Treg Octreotide Acetate A/H1N1 INFLUENZA VACCINE Calcium Folinate Pentahydrate Cx-037231 Ag-946 Phosphate Dexrazoxane Hydrochloride METAMIZOLE SODIUM Tomligisiran Cetuximab More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage IV Diabetic retinopathy B-cell lymphoma Tertiary adrenal insufficiency Eclampsia Primary hypogonadism Liver transplant rejection Propionic acidaemia Endometrial cancer metastatic Lung adenocarcinoma Torticollis Breast cancer recurrent Neoplasm Bone hypertrophy Retinitis pigmentosa More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. MENTUM, s.r.o.

MENTUM, s.r.o.

Ruzinovska 10, Bratislava, 820 07, Slovakia

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

    Recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Bulgaria Czechia Germany Hungary Poland Romania +1

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland Slovakia

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Czechia Germany Italy Romania Slovakia Spain

  • Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

    Not recruiting

    4 1
    Investigated Diseases:
    • Generalised anxiety disorder
    Investigated Drugs:
    • Ulotaront
    Bulgaria Estonia Finland Slovakia Spain Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!